• Clinical Evidence

Four-fold Decrease in Hypoglycemic Events: Easing the Burden for Nursing and Improving Patient Safety at UPMC

Image
Setting: UPMC Central Pennsylvania

Objective

UPMC Central Pennsylvania performed a three-month comparison before and after the implementation of EndoTool IV insulin dosing software at one hospital. The analysis focused on patients treated for hyperglycemic and Diabetic Ketoacidosis, excluding COVID patients due to their smaller representation in the patient population after EndoTool IV implementation.

Setting

UPMC Central Pennsylvania, a prominent healthcare institution, includes seven acute care hospitals, providing a total of 1,160 licensed beds.

Results

Data shows a decreased time on insulin infusion, decreased overall LOS, improved time to goal, decreased number of glucose checks and a four-fold decrease in hypoglycemic events.

What does this mean for nursing?

  • Decreased cognitive burden and task workload
  • Eliminated the need for nurses to interpret titration instructions
  • 46% decrease in blood glucose checks
  • Spent less time caring for a patient on an insulin infusion – decreasing time on infusion by about 17 hours per patient
  • Treated significantly fewer patients for hypoglycemia

What does this mean for the patient?

  • Fewer blood glucose checks
  • Decreased risk of hypoglycemia
  • Decreased LOS in the hospital

Conclusions

The four-fold decrease in hypoglycemic events showcases not only the effectiveness of EndoTool IV to improve patient outcomes but the platforms potential to revolutionize insulin dosing workflows for nurses in hospitalized settings. For the nursing staff, this advancement translates into reduced workloads, lowered cognitive burdens, and more streamlined processes, allowing them to provide better patient-centered care.

Objective

UPMC Central Pennsylvania performed a three-month comparison before and after the implementation of EndoTool IV insulin dosing software at one hospital. The analysis focused on patients treated for hyperglycemic and Diabetic Ketoacidosis, excluding COVID patients due to their smaller representation in the patient population after EndoTool IV implementation.

Setting

UPMC Central Pennsylvania, a prominent healthcare institution, includes seven acute care hospitals, providing a total of 1,160 licensed beds.

Results

Data shows a decreased time on insulin infusion, decreased overall LOS, improved time to goal, decreased number of glucose checks and a four-fold decrease in hypoglycemic events.

What does this mean for nursing?

  • Decreased cognitive burden and task workload
  • Eliminated the need for nurses to interpret titration instructions
  • 46% decrease in blood glucose checks
  • Spent less time caring for a patient on an insulin infusion – decreasing time on infusion by about 17 hours per patient
  • Treated significantly fewer patients for hypoglycemia

What does this mean for the patient?

  • Fewer blood glucose checks
  • Decreased risk of hypoglycemia
  • Decreased LOS in the hospital
Conclusions

The four-fold decrease in hypoglycemic events showcases not only the effectiveness of EndoTool IV to improve patient outcomes but the platforms potential to revolutionize insulin dosing workflows for nurses in hospitalized settings. For the nursing staff, this advancement translates into reduced workloads, lowered cognitive burdens, and more streamlined processes, allowing them to provide better patient-centered care.

References

Authors

Katharine Gambill, MSN, RN, CMSRN, Clinical Director, Acute Care Medical Surgical; Christie Muza, MSN, RN, NE-BC, Director, Clinical and Operations Informatics UPMC Central PA

Source

AANC Magnet and Pathway to Excellence Conference 2023

Year

2023

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

UPMC Central Pennsylvania performed a three-month comparison before and after the implementation of EndoTool IV insulin dosing software at one hospital. The analysis focused on patients treated for hyperglycemic and Diabetic Ketoacidosis, excluding COVID patients due to their smaller representation in the patient population after EndoTool IV implementation.

Setting

UPMC Central Pennsylvania, a prominent healthcare institution, includes seven acute care hospitals, providing a total of 1,160 licensed beds.

Results

Data shows a decreased time on insulin infusion, decreased overall LOS, improved time to goal, decreased number of glucose checks and a four-fold decrease in hypoglycemic events.

What does this mean for nursing?

  • Decreased cognitive burden and task workload
  • Eliminated the need for nurses to interpret titration instructions
  • 46% decrease in blood glucose checks
  • Spent less time caring for a patient on an insulin infusion – decreasing time on infusion by about 17 hours per patient
  • Treated significantly fewer patients for hypoglycemia

What does this mean for the patient?

  • Fewer blood glucose checks
  • Decreased risk of hypoglycemia
  • Decreased LOS in the hospital
Conclusions

The four-fold decrease in hypoglycemic events showcases not only the effectiveness of EndoTool IV to improve patient outcomes but the platforms potential to revolutionize insulin dosing workflows for nurses in hospitalized settings. For the nursing staff, this advancement translates into reduced workloads, lowered cognitive burdens, and more streamlined processes, allowing them to provide better patient-centered care.

References

Authors

Katharine Gambill, MSN, RN, CMSRN, Clinical Director, Acute Care Medical Surgical; Christie Muza, MSN, RN, NE-BC, Director, Clinical and Operations Informatics UPMC Central PA

Source

AANC Magnet and Pathway to Excellence Conference 2023

Year

2023

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.